Zentek Ltd.

TSXV ZEN.V

Zentek Ltd. EBITDA Margin for the year ending March 31, 2024: -37,154.53%

Zentek Ltd. EBITDA Margin is -37,154.53% for the year ending March 31, 2024, a -96.81% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Zentek Ltd. EBITDA Margin for the year ending March 31, 2023 was -18,878.52%, a -468.80% change year over year.
  • Zentek Ltd. EBITDA Margin for the year ending March 31, 2022 was -3,318.99%, a 97.90% change year over year.
  • Zentek Ltd. EBITDA Margin for the year ending March 31, 2021 was -158,345.73%.
Key data
Date EBITDA Margin EBIT Margin Depreciation and Amortization EBIT
Market news
TSXV: ZEN.V

Zentek Ltd.

CEO Mr. Gregory Fenton C.F.A.
IPO Date Dec. 23, 2010
Location Canada
Headquarters 1205 Amber Drive
Employees 24
Sector Materials
Industries
Chemicals & Advanced Materials Semiconductors
Description

Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada.

StockViz Staff

January 15, 2025

Any question? Send us an email